Search the site

The University of Manchester Library

In April 2016 Manchester eScholar was replaced by the University of Manchester’s new Research Information Management System, Pure. In the autumn the University’s research outputs will be available to search and browse via a new Research Portal. Until then the University’s full publication record can be accessed via a temporary portal and the old eScholar content is available to search and browse via this archive.

Synthesis and evaluation of small molecule inhibitors of pre-mRNA splicing to effectively modify gene expression

Kirchhoffer, Olivier Auguste

[Thesis]. Manchester, UK: The University of Manchester; 2019.

Access to files

Abstract

The spliceosome is a highly complex molecular machine that still holds a lot of secrets for contemporary biology. It plays a crucial role as one of the various mechanisms involved in generating a plethora of different proteins, from a limited amount of genetic information, sealed in the form of DNA in the nucleus of living cells. Previous studies have tried to dissect this complex mechanism by inhibiting the spliceosome, in order to study its biological properties. Interestingly a significant number of inhibitors found, which target the specific U2 snRNP unit of the spliceosome, have been reported to have anti-cancer activity. Some of the most promising compounds, which resulted from this drug development approach, have almost made it to the drug market at the time of writing, for their antitumor activity. A vast amount of research has emerged concerning the biological processes that ultimately led to this activity. Previous work within the Whitehead group, which focused on developing inhibitors of the U5 snRNP unit of the spliceosome, has led to the discovery of a compound derived from the steroidal antibiotic fusidic acid that displayed significant splicing inhibitory activity. Lithocholic acid later emerged as another potential starting point for developing small molecule inhibitors of the U5 snRNP, as it was found to have similar levels of inhibition as the hit compound derived from fusidic acid. Lithocholic acid was a good starting point for further SAR studies, as it isn't heavily functionalised, making it a robust compound that can easily be diversified. A variety of compounds were generated from it, with new structural features and additional functional groups that unravelled new information about the target protein. Splicing assays also revealed that several of these compounds have superseded the level of inhibition achieved by the previously outlined hit compound.

Additional content not available electronically

A CD with attach supplementary information has been submitted alongside the first version of the thesis

Bibliographic metadata

Type of resource:
Content type:
Administered thesis
Form of thesis:
Traditional
Type of submission:
Doctoral level ETD - final
Thesis title:
Synthesis and evaluation of small molecule inhibitors of pre-mRNA splicing to effectively modify gene expression
Degree type:
Master of Science by Research
Degree programme:
MSc by Research Chemistry
Publication date:
2019-11-25T10:39:29
Institution:
The University of Manchester
Location:
Manchester, UK
Total pages:
95
Abstract:
The spliceosome is a highly complex molecular machine that still holds a lot of secrets for contemporary biology. It plays a crucial role as one of the various mechanisms involved in generating a plethora of different proteins, from a limited amount of genetic information, sealed in the form of DNA in the nucleus of living cells. Previous studies have tried to dissect this complex mechanism by inhibiting the spliceosome, in order to study its biological properties. Interestingly a significant number of inhibitors found, which target the specific U2 snRNP unit of the spliceosome, have been reported to have anti-cancer activity. Some of the most promising compounds, which resulted from this drug development approach, have almost made it to the drug market at the time of writing, for their antitumor activity. A vast amount of research has emerged concerning the biological processes that ultimately led to this activity. Previous work within the Whitehead group, which focused on developing inhibitors of the U5 snRNP unit of the spliceosome, has led to the discovery of a compound derived from the steroidal antibiotic fusidic acid that displayed significant splicing inhibitory activity. Lithocholic acid later emerged as another potential starting point for developing small molecule inhibitors of the U5 snRNP, as it was found to have similar levels of inhibition as the hit compound derived from fusidic acid. Lithocholic acid was a good starting point for further SAR studies, as it isn't heavily functionalised, making it a robust compound that can easily be diversified. A variety of compounds were generated from it, with new structural features and additional functional groups that unravelled new information about the target protein. Splicing assays also revealed that several of these compounds have superseded the level of inhibition achieved by the previously outlined hit compound.
Non-digital content not deposited electronically:
A CD with attach supplementary information has been submitted alongside the first version of the thesis
Keyword(s):
Thesis main supervisor(s):
Thesis co-supervisor(s):
Degree grantor:
Language:
en

Institutional metadata

University researcher(s):
Academic department(s):

Record metadata

Manchester eScholar ID:
uk-ac-man-scw:322579
Created by:
Kirchhoffer, Olivier
Created:
25th November, 2019, 10:39:29
Last modified by:
Kirchhoffer, Olivier
Last modified:
4th December, 2020, 10:14:30

Can we help?

The library chat service will be available from 11am-3pm Monday to Friday (excluding Bank Holidays). You can also email your enquiry to us.